Medical Membranes Market - Trends & Forecast to 2020

“Growing healthcare and pharmaceutical industries are driving the demand of medical membranes “
The global medical membranes market is projected to reach USD 7.4 billion by 2020, registering a CAGR of 9.9% between 2015 and 2020. The market for medical membranes is directly proportional to the demand for medical devices in the healthcare and pharmaceutical industries. Many governments are taking initiatives to reduce costs and improve the quality of their healthcare infrastructure. Improving healthcare facilities will help in the upsurge of the healthcare market in the country along with the global healthcare industry. Upsurge in the healthcare facilities will increase the demand for medical products and will drive the demand of medical membranes.

“Hemodialysis, the fastest-growing application for medical membranes”

With changing lifestyle, the incidents of organ failures are increasing. According to Centers for Disease Control and Prevention, 1 in 10 American, that is more than 26 million people in the U.S. have some level of chronic kidney disease. Membranes are widely used in the hemodialysis treatment. The rising incidents of hemodialysis are driving the demand of medical membranes.

“Asia-Pacific, the fastest-growing medical membranes market”
Asia-Pacific is estimated to be the fastest-growing market for medical membranes. The growing demand for high purity products due to increasing regulations and technological advancements in medical membranes market are projected to drive the demand of medical membranes in the next five years. In Asia-Pacific, China and India are expected to witness high demand of medical membranes between 2015 and 2020. The Indian and Chinese medical membranes industries are the most promising industries in Asia-Pacific due to increasing cases of diabetes and growing healthcare and pharmaceutical market. Germany and the U.S. are the major countries having the highest share in the European and North American regions, respectively. With the recent expansion activities by key players in the Asia-Pacific region; the demand of medical membranes in this region is projected to register the highest growth rate between 2015 and 2020.
This study has been validated through primaries conducted with various industry experts, globally. These primary sources have been divided under three categories: By Company; By Designation; and By Region.
‧ By Company Type- Tier 1- 22%, Tier 2- 33% and Tier 3- 45%
‧ By Designation- C Level- 12%, Director Level- 25%, and Others- 63%
‧ By Region- North America- 22%, Europe- 11%, Asia-Pacific- 56%, and RoW- 11%
The report also provides company profiles and competitive strategies adopted by the major market players such as 3M International (U.S.), MANN+HUMMELL GMBH (Germany), and Asahi Kasei Corporation (Japan) among others.
The report will help the market leaders/new entrants in this market in the following ways:
1. This report segments the medical membranes market comprehensively and provides the closest approximations of the revenue for the overall market and subsegments across the different verticals and regions.
2. The report helps stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, and opportunities.
3. This report will help stakeholders to better understand the competitor and gain more insights about the business. The competitive landscape section includes competitor ecosystem, new product developments, partnerships, and mergers & acquisitions.

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.1.1 SECONDARY DATA 16
2.1.1.1 Data from secondary sources 16
2.1.2 PRIMARY DATA 17
2.1.2.1 Data from primary sources 17
2.1.2.2 Key industry insights 18
2.1.2.3 Breakdown of primary interviews 18
2.2 MARKET SIZE ESTIMATION 18
2.2.1 BOTTOM-UP APPROACH 19
2.2.2 TOP-DOWN APPROACH 19
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 21
2.4.1 ASSUMPTIONS 21
2.4.2 LIMITATIONS 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 SIGNIFICANT MARKET OPPORTUNITIES FOR MEMBRANES 25
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 29
5.2 MARKET SEGMENTATION 29
5.2.1 MEDICAL MEMBRANES MARKET SEGMENTATION 30
5.2.2 MEDICAL MEMBRANES MARKET, BY REGION 31
5.3 MARKET DYNAMICS 31
5.3.1 DRIVERS 32
5.3.1.1 Increasing healthcare and pharmaceutical industries 32
5.3.1.2 Growing demand for artificial organs 32
5.3.1.3 Requirement of selective separation along with high level of purity 33
5.3.2 RESTRAINTS 33
5.3.2.1 Financial challenges to provide products at affordable price 33
5.3.2.2 Long in-process validation process 33
5.3.3 OPPORTUNITIES 33
5.3.3.1 Growing demand for membranes in the emerging economies 33
5.3.4 CHALLENGES 33
5.3.4.1 Life span of membranes 33
6 INDUSTRY TRENDS 35
6.1 INTRODUCTION 35
6.2 VALUE-CHAIN ANALYSIS 35
6.2.1 RAW MATERIAL SUPPLIERS 36
6.2.2 MEMBRANE MANUFACTURERS OR FORMULATORS 36
6.2.3 END USERS 36
6.3 PORTER’S FIVE FORCES ANALYSIS 36
6.3.1 THREAT OF NEW ENTRANTS 37
6.3.2 THREAT OF SUBSTITUTES 37
6.3.3 BARGAINING POWER OF BUYERS 38
6.3.4 BARGAINING POWER OF SUPPLIERS 38
6.3.5 INTENSITY OF RIVALRY 38
7 MEDICAL MEMBRANES MARKET, BY CHEMISTRY 39
7.1 INTRODUCTION 40
7.2 POLYVINYLIDENE FLUORIDE (PVDF) 42
7.3 POLYSULFONE (PS) 42
7.4 POLYTETRAFLUOROETHYLENE (PTFE) 43
7.5 POLYETHYLENE (PE) 44
7.6 MODIFIED ACRYLICS 45
7.7 OTHERS 46
8 MEDICAL MEMBRANES MARKET, BY TECHNOLOGY 47
8.1 INTRODUCTION 48
8.2 MICROFILTRATION (MF) 49
8.3 REVERSE OSMOSIS & DIALYSIS 50
8.4 ULTRAFILTRATION (UF) 52
8.5 NANOFILTRATION 52
8.6 OTHERS 54
?
9 MEDICAL MEMBRANES MARKET, BY APPLICATION 55
9.1 INTRODUCTION 56
9.2 PHARMACEUTICAL FILTRATION 57
9.3 HEMODIALYSIS 58
9.4 DRUG DELIVERY 59
9.5 IV INFUSION FILTERS AND STERILE FILTRATION 60
9.6 OTHERS 62
10 MEDICAL MEMBRANES MARKET, BY REGION 63
10.1 INTRODUCTION 64
10.2 NORTH AMERICA 65
10.2.1 U.S. 68
10.2.2 CANADA 70
10.2.3 MEXICO 72
10.3 ASIA-PACIFIC 74
10.3.1 JAPAN 77
10.3.2 CHINA 79
10.3.3 INDIA 81
10.3.4 REST OF ASIA-PACIFIC 83
10.4 EUROPE 86
10.4.1 GERMANY 88
10.4.2 FRANCE 90
10.4.3 U.K. 92
10.4.4 REST OF EUROPE 94
10.5.1 BRAZIL 98
10.5.2 OTHERS 99
11 COMPETITIVE LANDSCAPE 102
11.1 OVERVIEW 102
11.1.1 MERGERS & ACQUISITIONS 102
11.1.2 NEW PRODUCT LAUNCHES 103
12 COMPANY PROFILES 104
12.1 INTRODUCTION 104
(Overview, Financials, Products & Services, Strategy, and Developments)*
12.2 ASAHI KASEI CORPORATION 105
12.3 THE 3M COMPANY 107
12.4 HYFLUX LTD. 110
12.5 MERCK MILLIPORE (EMD MILLIPORE) 112
12.6 PALL CORPORATION 115
12.7 KOCH MEMBRANE SYSTEMS, INC. 117
12.8 W. L. GORE & ASSOCIATES, INC. 119
12.9 GE WATER & PROCESS TECHNOLOGIES 121
12.10 MICRODYN-NADIR GMBH 122
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted companies.
13 APPENDIX 123
13.1 DISCUSSION GUIDE 123
13.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 127
13.3 AVAILABLE CUSTOMIZATIONS 127
13.4 RELATED REPORTS 128